The effect of cinnamon supplementation on cardiovascular risk factors in adults: a GRADE assessed systematic review, dose-response and meta-analysis of randomized controlled trials.
- 2025-07-03
- Journal of health, population, and nutrition 44(1)
- Ali Jafari
- Helia Mardani
- Amir Hossein Faghfouri
- Minoo AhmadianMoghaddam
- Vali Musazadeh
- Alireza Alaghi
- PubMed: 40611215
- DOI: 10.1186/s41043-025-00967-3
Study Design
- Type
- Meta-Analysis
- Methods
- Relevant studies were identified through electronic searches of databases, including Web of Science, PubMed, Central, Scopus, and Embase, up to July 2024.
Background
Numerous clinical studies have suggested that cinnamon supplementation may be effective for cardiovascular disease risk factors, but the findings are controversial. This comprehensive systematic review and meta-analysis aimed to assess the impact of cinnamon supplementation on cardiovascular disease risk factors.Methods
Relevant studies were identified through electronic searches of databases, including Web of Science, PubMed, Central, Scopus, and Embase, up to July 2024.Results
Forty-nine studies were included. Cinnamon supplementation significantly reduced WC (SMD = - 0.40; 95% (CI): - 0.73, - 0.06), DBP (SMD = - 1.04; 95% CI: - 1.54, - 0.55), SBP (SMD = - 0.85; 95% CI: - 1.54, - 0.16), fasting glucose (SMD = - 1.28; 95% CI: - 1.65, - 0.90), fasting insulin (SMD = - 0.26; 95% CI: - 0.50, - 0.02), HbA1c (SMD = - 0.71; 95% CI: - 1.02, - 0.40), HOMA-IR (SMD = - 0.54; 95% CI: - 0.82, - 0.26), postprandial blood glucose (SMD = - 2.28; 95% CI: - 3.48, - 1.08), CRP (SMD = - 0.78; 95% CI: - 1.28, - 0.27), LDL-C (SMD = - 0.71; 95% CI: - 1.02, - 0.40), total cholesterol (TC) (SMD = - 1.15; 95% CI: - 1.55, - 0.75), triglycerides (TG) (SMD = - 0.91; 95% CI: - 1.25, - 0.56), and MDA (SMD = - 0.76; 95% CI: - 1.07, - 0.45). Additionally, cinnamon supplementation significantly elevated HDL-C levels (SMD = 0.56; 95% CI: 0.23, 0.89).Conclusion
Cinnamon supplementation demonstrated significant benefits in improving cardiovascular risk factors. These findings suggest its potential as an adjunct therapy for improving cardiovascular disease risk factors.Research Insights
cinnamon supplementation significantly elevated HDL-C levels (SMD = 0.56; 95% CI: 0.23, 0.89)
- Effect
- Beneficial
- Effect size
- Moderate
CRP (SMD = - 0.78; 95% CI: - 1.28, - 0.27)
- Effect
- Beneficial
- Effect size
- Moderate
DBP (SMD = - 1.04; 95% CI: - 1.54, - 0.55)
- Effect
- Beneficial
- Effect size
- Large
fasting glucose (SMD = - 1.28; 95% CI: - 1.65, - 0.90)
- Effect
- Beneficial
- Effect size
- Large
HbA1c (SMD = - 0.71; 95% CI: - 1.02, - 0.40)
- Effect
- Beneficial
- Effect size
- Moderate
HOMA-IR (SMD = - 0.54; 95% CI: - 0.82, - 0.26)
- Effect
- Beneficial
- Effect size
- Moderate
fasting insulin (SMD = - 0.26; 95% CI: - 0.50, - 0.02)
- Effect
- Beneficial
- Effect size
- Small
LDL-C (SMD = - 0.71; 95% CI: - 1.02, - 0.40)
- Effect
- Beneficial
- Effect size
- Moderate
MDA (SMD = - 0.76; 95% CI: - 1.07, - 0.45)
- Effect
- Beneficial
- Effect size
- Moderate
postprandial blood glucose (SMD = - 2.28; 95% CI: - 3.48, - 1.08)
- Effect
- Beneficial
- Effect size
- Large
SBP (SMD = - 0.85; 95% CI: - 1.54, - 0.16)
- Effect
- Beneficial
- Effect size
- Large
total cholesterol (TC) (SMD = - 1.15; 95% CI: - 1.55, - 0.75)
- Effect
- Beneficial
- Effect size
- Large
triglycerides (TG) (SMD = - 0.91; 95% CI: - 1.25, - 0.56)
- Effect
- Beneficial
- Effect size
- Large
Cinnamon supplementation significantly reduced WC (SMD = - 0.40; 95% (CI): - 0.73, - 0.06)
- Effect
- Beneficial
- Effect size
- Moderate